{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:14:02Z","timestamp":1793740442346,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"International Clinical Exchange Program of Health Commission of Zhejiang Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06648-3","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T14:49:10Z","timestamp":1749826150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["TTI1 contributes to radioresistance by activating ATM pathway in rectal cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Jingying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"6648_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"6648_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13014-020-01695-0","volume":"15","author":"F Roeder","year":"2020","unstructured":"Roeder F, Meldolesi E, Gerum S, Valentini V, R\u00f6del C. Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review. Radiat Oncol. 2020;15:262.","journal-title":"Radiat Oncol"},{"key":"6648_CR3","volume":"10","author":"I Abraha","year":"2018","unstructured":"Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R, De Florio R, Valentini V. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018;10: CD002102.","journal-title":"Cochrane Database Syst Rev"},{"key":"6648_CR4","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"C R\u00f6del","year":"2005","unstructured":"R\u00f6del C, Martus P, Papadoupolos T, F\u00fczesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688\u201396.","journal-title":"J Clin Oncol"},{"key":"6648_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.radonc.2020.09.026","volume":"154","author":"MA Gambacorta","year":"2021","unstructured":"Gambacorta MA, Masciocchi C, Chiloiro G, Meldolesi E, Macchia G, van Soest J, Peters F, Collette L, G\u00e9rard JP, Ngan S, R\u00f6del CC, Damiani A, Dekker A, Valentini V. Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials. Radiother Oncol. 2021;154:154\u201360.","journal-title":"Radiother Oncol"},{"key":"6648_CR6","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ijrobp.2017.03.023","volume":"98","author":"YJ Ha","year":"2017","unstructured":"Ha YJ, Tak KH, Kim CW, Roh SA, Choi EK, Cho DH, Kim JH, Kim SK, Kim SY, Kim YS, Kim JC. PSMB8 as a candidate marker of responsiveness to preoperative radiation therapy in rectal cancer patients. Int J Radiat Oncol Biol Phys. 2017;98:1164\u201373.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6648_CR7","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.934116","volume":"27","author":"W Bouleftour","year":"2021","unstructured":"Bouleftour W, Rowinski E, Louati S, Sotton S, Wozny AS, Moreno-Acosta P, Mery B, Rodriguez-Lafrasse C, Magne N. A review of the role of hypoxia in radioresistance in cancer therapy. Med Sci Monit. 2021;27: e934116.","journal-title":"Med Sci Monit"},{"key":"6648_CR8","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/ijc.23925","volume":"123","author":"O De Wever","year":"2008","unstructured":"De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 2008;123:2229\u201338.","journal-title":"Int J Cancer"},{"key":"6648_CR9","first-page":"90","volume":"22","author":"M Ansems","year":"2020","unstructured":"Ansems M, Span PN. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts. Clin Transl Radiat Oncol. 2020;22:90\u20137.","journal-title":"Clin Transl Radiat Oncol"},{"key":"6648_CR10","doi-asserted-by":"publisher","first-page":"86816","DOI":"10.18632\/oncotarget.13559","volume":"7","author":"R Wang","year":"2016","unstructured":"Wang R, Wei J, Zhang S, Wu X, Guo J, Liu M, Du K, Xu J, Peng L, Lv Z, You W, Xiong Y, Fu Z. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer. Oncotarget. 2016;7:86816\u201328.","journal-title":"Oncotarget"},{"key":"6648_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ajhg.2023.01.006","volume":"110","author":"M Serey-Gaut","year":"2023","unstructured":"Serey-Gaut M, Cortes M, Makrythanasis P, Suri M, Taylor AMR, Sullivan JA, Asleh AN, Mitra J, Dar MA, McNamara A, Shashi V, Dugan S, Song X, Rosenfeld JA, Cabrol C, Iwaszkiewicz J, Zoete V, Pehlivan D, Akdemir ZC, Roeder ER, Littlejohn RO, Dibra HK, Byrd PJ, Stewart GS, Geckinli BB, Posey J, Westman R, Jungbluth C, Eason J, Sachdev R, Evans CA, Lemire G, VanNoy GE, O\u2019Donnell-Luria A, Mau-Them FT, Juven A, Piard J, Nixon CY, Zhu Y, Ha T, Buckley MF, Thauvin C, Essien Umanah GK, Van Maldergem L, Lupski JR, Roscioli T, Dawson VL, Dawson TM, Antonarakis SE. Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly. Am J Hum Genet. 2023;110:499\u2013515.","journal-title":"Am J Hum Genet"},{"issue":"17","key":"6648_CR12","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1101\/gad.1934210","volume":"24","author":"KE Hurov","year":"2010","unstructured":"Hurov KE, Cotta-Ramusino C, Elledge SJ. A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev. 2010;24(17):1939\u201350.","journal-title":"Genes Dev"},{"key":"6648_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167370","volume":"434","author":"Y Kim","year":"2022","unstructured":"Kim Y, Park J, Joo SY, Kim BG, Jo A, Lee H, Cho Y. Structure of the human TELO2-TTI1-TTI2 complex. J Mol Biol. 2022;434: 167370.","journal-title":"J Mol Biol"},{"key":"6648_CR14","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1101\/gad.1934210","volume":"24","author":"KE Hurov","year":"2010","unstructured":"Hurov KE, Cotta-Ramusino C, Elledge SJ. A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev. 2010;24:1939\u201350.","journal-title":"Genes Dev"},{"key":"6648_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s13046-024-03234-1","volume":"43","author":"EA Smith","year":"2024","unstructured":"Smith EA, Belote RL, Cruz NM, Moustafa TE, Becker CA, Jiang A, Alizada S, Prokofyeva A, Chan TY, Seasor TA, Balatico M, Cortes-Sanchez E, Lum DH, Hyngstrom JR, Zeng H, Deacon DC, Grossmann AH, White RM, Zangle TA, Judson-Torres RL. Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. J Exp Clin Cancer Res. 2024;43:317.","journal-title":"J Exp Clin Cancer Res"},{"key":"6648_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100984","volume":"51","author":"M Smithson","year":"2024","unstructured":"Smithson M, Diffalha SA, Irwin RK, Williams G, McLeod MC, Somasundaram V, Bellis SL, Hardiman KM. ST6GAL1 is associated with poor response to chemoradiation in rectal cancer. Neoplasia. 2024;51: 100984.","journal-title":"Neoplasia"},{"key":"6648_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12967-023-04054-1","volume":"21","author":"Y Sun","year":"2023","unstructured":"Sun Y, Zhang X, Jin C, Yue K, Sheng D, Zhang T, Dou X, Liu J, Jing H, Zhang L, Yue J. Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy. J Transl Med. 2023;21:221.","journal-title":"J Transl Med"},{"key":"6648_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1182\/blood-2017-07-746396","volume":"131","author":"HL Ou","year":"2018","unstructured":"Ou HL, Schumacher B. DNA damage responses and p53 in the aging process. Blood. 2018;131:488\u201395.","journal-title":"Blood"},{"key":"6648_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/HP.0000000000001601","volume":"123","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Cao F, Liu H. Radiation-induced cell death and its mechanisms. Health Phys. 2022;123:376\u201386.","journal-title":"Health Phys"},{"key":"6648_CR20","doi-asserted-by":"publisher","first-page":"42462","DOI":"10.1074\/jbc.C100466200","volume":"276","author":"S Burma","year":"2001","unstructured":"Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001;276:42462\u20137.","journal-title":"J Biol Chem"},{"key":"6648_CR21","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo LJ, Yang LX. Gamma-H2AX\u2014a novel biomarker for DNA double-strand breaks. In Vivo. 2008;22:305\u20139.","journal-title":"In Vivo"},{"key":"6648_CR22","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1038\/s41467-021-26079-0","volume":"12","author":"SM Ambj\u00f8rn","year":"2021","unstructured":"Ambj\u00f8rn SM, Duxin JP, Hertz EPT, Nasa I, Duro J, Kruse T, Lopez-Mendez B, Rymarczyk B, Cressey LE, van Overeem HT, Kettenbach AN, Oestergaard VH, Lisby M, Nilsson J. A complex of BRCA2 and PP2A-B56 is required for DNA repair by homologous recombination. Nat Commun. 2021;12:5748.","journal-title":"Nat Commun"},{"key":"6648_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ijms23010523","volume":"23","author":"S Ueno","year":"2022","unstructured":"Ueno S, Sudo T, Hirasawa A. ATM: functions of ATM kinase and its relevance to hereditary tumors. Int J Mol Sci. 2022;23:523.","journal-title":"Int J Mol Sci"},{"key":"6648_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403038121","volume":"121","author":"Z Xiang","year":"2024","unstructured":"Xiang Z, Hou G, Zheng S, Lu M, Li T, Lin Q, Liu H, Wang X, Guan T, Wei Y, Zhang W, Zhang Y, Liu C, Li L, Lei QY, Hu Y. ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs. Proc Natl Acad Sci USA. 2024;121: e2403038121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6648_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41418-019-0397-3","volume":"27","author":"D Huo","year":"2020","unstructured":"Huo D, Chen H, Cheng Y, Song X, Zhang K, Li MJ, Xuan C. JMJD6 modulates DNA damage response through downregulating H4K16ac independently of its enzymatic activity. Cell Death Differ. 2020;27:1052\u201366.","journal-title":"Cell Death Differ"},{"key":"6648_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.20600","volume":"58","author":"X Deng","year":"2005","unstructured":"Deng X, Ljunggren-Rose A, Maas K, Sriram S. Defective ATM-p53-mediated apoptotic pathway in multiple sclerosis. Ann Neurol. 2005;58:577\u201384.","journal-title":"Ann Neurol"},{"key":"6648_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-022-01360-x","volume":"15","author":"S Li","year":"2022","unstructured":"Li S, Wang L, Wang Y, Zhang C, Hong Z, Han Z. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. J Hematol Oncol. 2022;15:147.","journal-title":"J Hematol Oncol"},{"key":"6648_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canlet.2012.01.007","volume":"332","author":"WP Roos","year":"2013","unstructured":"Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett. 2013;332:237\u201348.","journal-title":"Cancer Lett"},{"key":"6648_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/cas.15668","volume":"114","author":"LX Zhang","year":"2023","unstructured":"Zhang LX, Yang X, Wu ZB, Liao ZM, Wang DG, Chen SW, Lu F, Wu YB, Zhu SQ. TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway. Cancer Sci. 2023;114:855\u201369.","journal-title":"Cancer Sci"},{"key":"6648_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41571-022-00709-y","volume":"20","author":"JM Price","year":"2023","unstructured":"Price JM, Prabhakaran A, West CML. Predicting tumour radiosensitivity to deliver precision radiotherapy. Nat Rev Clin Oncol. 2023;20:83\u201398.","journal-title":"Nat Rev Clin Oncol"},{"key":"6648_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.mrfmmm.2013.07.007","volume":"750","author":"R Scully","year":"2013","unstructured":"Scully R, Xie A. Double strand break repair functions of histone H2AX. Mutat Res. 2013;750:5\u201314.","journal-title":"Mutat Res"},{"key":"6648_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0092-8674(03)00567-1","volume":"114","author":"A Celeste","year":"2003","unstructured":"Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA, Eckhaus M, Ried T, Bonner WM, Nussenzweig A. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell. 2003;114:371\u201383.","journal-title":"Cell"},{"key":"6648_CR33","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1126\/science.1069398","volume":"296","author":"A Celeste","year":"2002","unstructured":"Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science. 2002;296:922\u20137.","journal-title":"Science"},{"key":"6648_CR34","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.3390\/jcm12083014","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Wang X, Hou X, Ma X. Could inhibiting the DNA damage repair checkpoint rescue immune-checkpoint-inhibitor-resistant endometrial cancer? J Clin Med. 2023;12:3014.","journal-title":"J Clin Med"},{"key":"6648_CR35","doi-asserted-by":"publisher","first-page":"11655","DOI":"10.1038\/ncomms11655","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Chu H, Lv M, Zhang Z, Qiu S, Liu H, Shen X, Wang W, Cai G. Structure of the intact ATM\/Tel1 kinase. Nat Commun. 2016;7:11655.","journal-title":"Nat Commun"},{"key":"6648_CR36","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.1128\/MCB.01382-07","volume":"27","author":"Y Sun","year":"2007","unstructured":"Sun Y, Xu Y, Roy K, Price BD. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol Cell Biol. 2007;27:8502\u20139.","journal-title":"Mol Cell Biol"},{"key":"6648_CR37","doi-asserted-by":"publisher","first-page":"13182","DOI":"10.1073\/pnas.0504211102","volume":"102","author":"Y Sun","year":"2005","unstructured":"Sun Y, Jiang X, Chen S, Fernandes N, Price BD. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci USA. 2005;102:13182\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6648_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13046-024-03078-9","volume":"43","author":"P Sanese","year":"2024","unstructured":"Sanese P, De Marco K, Lepore Signorile M, La Rocca F, Forte G, Latrofa M, Fasano C, Disciglio V, Di Nicola E, Pantaleo A, Bianco G, Spilotro V, Ferroni C, Tubertini M, Labarile N, De Marinis L, Armentano R, Gigante G, Lantone V, Lantone G, Naldi M, Bartolini M, Varchi G, Del Rio A, Grossi V, Simone C. The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance. J Exp Clin Cancer Res. 2024;43:151.","journal-title":"J Exp Clin Cancer Res"},{"key":"6648_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.56499\/jppres21.1047_9.4.484","volume":"9","author":"MH Widyananda","year":"2021","unstructured":"Widyananda MH, Pratama SK, Samoedra RS, Sari FN, Kharisma VD, Ansori ANM, Antonius Y. Molecular docking study of sea urchin (Arbacia lixula) peptides as multi-target inhibitor for non-small cell lung cancer (NSCLC) associated proteins. J Pharm Pharmacogn Res. 2021;9:484\u201396.","journal-title":"J Pharm Pharmacogn Res"},{"key":"6648_CR40","doi-asserted-by":"publisher","first-page":"817","DOI":"10.5530\/pj.2022.14.173","volume":"14","author":"V Jakhmola","year":"2022","unstructured":"Jakhmola V, Parashar T, Ghildiyal P, Ansori AN, Sharma RK, Rao N, et al. An in silico study to explore the role of EGFR in ovarian cancer. Pharmacogn J. 2022;14:817\u201321.","journal-title":"Pharmacogn J"},{"key":"6648_CR41","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.5455\/OVJ.2024.v14.i10.12","volume":"14","author":"AB Achmad","year":"2024","unstructured":"Achmad AB, Proboningrat A, Ansori ANM, Fadholly A, Rochmi SE, Samsudin RR, Hidayatik N, Hendarti GA, Jayanti S. Stem bark ethanolic extract of Pinus merkusii induces caspase 9-mediated apoptosis in HeLa cells. Open Vet J. 2024;14:2628\u201333.","journal-title":"Open Vet J"},{"key":"6648_CR42","doi-asserted-by":"publisher","first-page":"1281731","DOI":"10.3389\/fendo.2023.1281731","volume":"14","author":"L Scappaticcio","year":"2023","unstructured":"Scappaticcio L, Ansori ANM, Trimboli P. Editorial: cancer-related hypercalcemia and potential treatments. Front Endocrinol (Lausanne). 2023;14:1281731.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06648-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T17:03:35Z","timestamp":1749834215000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06648-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6648"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06648-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethical Committee of The First Affiliated Hospital of Wenzhou Medical University. All patients were given informed written consent. The study was approved by the Medical Ethical Committee of The First Affiliated Hospital of Wenzhou Medical University. All of the animal experiments were approved by Institutional Animal Care and Use Committee in the First Affiliated Hospital of Wenzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript for submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"652"}}